NEC and Chugai Pharmaceutical use AI to potentially enhance cancer treatment in Japan

Japan-based NEC Corporation, in collaboration with Chugai Pharmaceutical Co., has conducted an experiment usin...

June 19, 2025 | Thursday | News
"Puerto Rico: America’s Pharma Powerhouse with Global Ambitions"

  Ella Woger-Nieves, Chief Executive Officer of Invest Puerto Rico, spoke to BioSpectrum Asia and BioSpectrum Indi...

June 18, 2025 | Wednesday | News
Immuno Cure and PharmaJet advance novel HIV therapeutic DNA vaccine using needle-free technology in humans

Immuno Cure BioTech, a clinical-stage biotechnology startup based in Hong Kong Science Park, has announced its upcoming ...

June 19, 2025 | Thursday | News
Korean biopharma firm Celltrion opens new UK headquarters in Uxbridge

Celltrion UK has officially opened its new UK headquarters at the Charter Building in Uxbridge, UK, reinforcing the comp...

June 19, 2025 | Thursday | News
AstraZeneca inks collaboration worth $3.6 B with CSPC Pharma focused on AI-enabled research in China

AstraZeneca has entered a strategic research collaboration with Shijiazhuang City-based CSPC Pharmaceuticals Group Limit...

June 18, 2025 | Wednesday | News
Avata Biosciences partners with Oceanus Bio for developing oral cannabidiol therapies to address Epilepsy and Schizophrenia

UK-based Avata Biosciences Holdings has signed a co-development and licensing agreement with Oceanus Bio, Inc. for the e...

June 18, 2025 | Wednesday | News
Abu Dhabi govt partners with Boehringer Ingelheim to advance life science innovation

The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in Abu Dhabi, has sig...

June 17, 2025 | Tuesday | News
Cartherics COO Dr Ian Nisbet on the promise of CAR-NK cells for cancer and endometriosis at BIO 2025

Dr Ian Nisbet, Chief Operating Officer and co-founder of Cartherics, brings over three decades of biotech leadership exp...

June 16, 2025 | Monday | News
Korea's Mezzion expands Udenafil pipeline to target multi-billion dollar kidney disease market

South Korea-based Mezzion Pharma Co., a leader in rare disease therapeutics, has announced the expansion of its udenafil...

June 13, 2025 | Friday | News
Mitsubishi Research Institute and Astellas collaborate to support pharma startups in Japan

Mitsubishi Research Institute, Inc.  and Astellas Pharma Inc. have agreed on a Memorandum of Understanding (MoU) to...

June 13, 2025 | Friday | News
Indian startup ZeroHarm Sciences plans expansion to UK & GCC markets

ZeroHarm Sciences, India’s pioneering clean-label nutraceutical company, is embarking on an aggressive global expa...

June 13, 2025 | Friday | News
DKSH strengthens healthcare supply chain with warehouse expansion in Brunei

DKSH Brunei, a leading provider of Market Expansion Services in Asia and beyond, has officially inaugurated its newly ex...

June 13, 2025 | Friday | News
Singapore's Specialised Therapeutics makes new additions to oncology portfolio in APAC region

Singapore-based biopharmaceutical company Specialised Therapeutics (ST) has expanded its existing supply and d...

June 13, 2025 | Friday | News
Korean firm Daewoong Pharmaceutical advances drug discovery programmes

Swedish biotech company Salipro Biotech AB has entered into a research collaboration with South Korea headquartered Daew...

June 10, 2025 | Tuesday | News
South Korea's AriBio licenses Alzheimer’s drug to Arcera in $600 M deal

AriBio Co., a South Korean biopharmaceutical company specialising in neurodegenerative diseases, and a Swiss pharmaceuti...

June 10, 2025 | Tuesday | News
WuXi Biologics begins construction of microbial manufacturing site in China

WuXi Biologics, a leading global Contract Research, Development and Manufacturing Organization (CRDMO), has kicked off c...

June 10, 2025 | Tuesday | News
Samsung Bioepis enters into strategic partnership with Nipro for commercialisation of multiple biosimilars in Japan

South Korea-based Samsung Bioepis Co. has entered into a license, development and commercialisation agreement with Nipro...

June 9, 2025 | Monday | News
Alvotech and Dr. Reddy’s to co-develop biosimilar candidate to Keytruda® (pembrolizumab)

Iceland-based Alvotech, a global biotech company specialising in the development and manufacture of biosimilar medicines...

June 7, 2025 | Saturday | News